The U.S. Department of Energy has approved the Documented Safety Analysis for Oklo Isotopes' Groves Isotope Test Reactor in Texas under the Reactor Pilot Program, moving the project into final pre-startup review. With both preliminary and final safety analyses cleared, the facility advances toward readiness review, fuel loading, and a targeted first criticality in July 2026. The milestone marks the first advanced reactor to achieve DSA approval on privately owned land with a fully commercial supply chain under DOE oversight.
DOE Approves Documented Safety Analysis for Groves Reactor
The DSA serves as the facility's final safety basis, grounded in detailed technical analysis of hazards, safety controls, and operating requirements for safe startup. Its approval follows DOE's earlier acceptance of the Preliminary Documented Safety Analysis, which established the preliminary safety basis during design and construction. The remaining steps are DOE's readiness review and startup approval, after which Groves will be authorized to receive and load nuclear fuel, conduct startup testing, and proceed toward first criticality. Oklo is targeting that milestone for July 2026, less than a year after breaking ground.
First Commercial-Pathway Advanced Reactor Under DOE Pilot Program
Groves is the first advanced reactor project to receive DSA approval on privately owned land with wholly commercially sourced fuel, equipment, and systems delivered by the private sector, according to Oklo co-founder and CEO Jacob DeWitte. Full civil construction and operations are led entirely by a private-sector team under DOE oversight, making it a representative facility for future commercial deployments Oklo intends to build and operate. DeWitte noted that DOE demonstrated remarkable capability to review and reach this milestone for a facility of this type outside a national laboratory on this timescale, providing a blueprint for accelerating advanced reactor deployment while maintaining rigorous safety processes.
Groves Advances Domestic Isotope Supply Chain
The reactor supports development of Oklo's isotope business and aims to establish a stronger domestic supply chain for critical isotopes used in cancer diagnosis and treatment, advanced manufacturing, scientific research, space exploration, and national security applications. Many important isotopes are currently sourced from overseas suppliers or produced in aging facilities, creating supply risks for U.S. hospitals, industry, researchers, and government users. By starting with a pilot facility, Oklo's isotopes business has developed operating procedures, evaluated reactor system performance, and will validate production processes to build dependable domestic isotope production at commercial scale.
Key Takeaways
- DOE approved both the Preliminary and Documented Safety Analyses for Groves, advancing the project to final pre-startup review with readiness review and startup approval remaining before fuel loading.
- Oklo targets first criticality for the Groves reactor in July 2026, less than a year after breaking ground on the Texas site.
- Groves is the first advanced reactor project to receive DSA approval on privately owned land with commercially sourced fuel and equipment under the DOE Reactor Pilot Program.
EnergyInsyte's Take
The DSA approval validates a commercial deployment pathway for advanced reactors under DOE's Reactor Pilot Program, but readiness review and startup approval remain as critical gating steps. Executives should monitor whether the July 2026 criticality target holds and whether this private-land, commercial-supply-chain model scales for Oklo's broader fast fission power plant ambitions.
Source: Businesswire
